Chemokines in cardiac fibrosis

Frangogiannis, 2019, Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities, Mol Aspects Med, 65, 70, 10.1016/j.mam.2018.07.001 Okyere, 2020, Leukocyte-dependent regulation of cardiac fibrosis, Front Physiol, 11, 301, 10.3389/fphys.2020.00301 Griffith, 2014, Chemokines and chemokine receptors: positioning cells for host defense and immunity, Annu Rev Immunol, 32, 659, 10.1146/annurev-immunol-032713-120145 Dobaczewski, 2009, Chemokines and cardiac fibrosis, Front Biosci (Schol Ed), 1, 391, 10.2741/s33 Roh, 2018, Chemokines and chemokine receptors in the development of NAFLD, Adv Exp Med Biol, 1061, 45, 10.1007/978-981-10-8684-7_4 Frangogiannis, 2004, Chemokines in the ischemic myocardium: from inflammation to fibrosis, Inflamm Res, 53, 585, 10.1007/s00011-004-1298-5 Humeres, 2019, Fibroblasts in the infarcted, remodeling, and failing heart, JACC Basic Transl Sci, 4, 449, 10.1016/j.jacbts.2019.02.006 Pakshir, 2020, The myofibroblast at a glance, J Cell Sci, 133, 10.1242/jcs.227900 Frangogiannis, 2020, Transforming Growth Factor (TGF)-beta in tissue fibrosis, J Exp Med, 217, 10.1084/jem.20190103 Wynn, 2016, Macrophages in tissue repair, regeneration, and fibrosis, Immunity, 44, 450, 10.1016/j.immuni.2016.02.015 Blanton, 2019, T-cell recruitment to the heart: friendly guests or unwelcome visitors?, Am J Physiol Heart Circ Physiol, 317, H124, 10.1152/ajpheart.00028.2019 Levick, 2012, Cardiac mast cells: the centrepiece in adverse myocardial remodelling, Cardiovasc Res, 89, 12, 10.1093/cvr/cvq272 Frangogiannis, 1998, Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion, Circulation, 98, 687, 10.1161/01.CIR.98.7.687 Bucala, 1994, Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair, Mol Med, 1, 71, 10.1007/BF03403533 Haider, 2019, Transition of macrophages to fibroblast-like cells in healing myocardial infarction, J Am Coll Cardiol, 74, 3124, 10.1016/j.jacc.2019.10.036 Kanisicak, 2016, Genetic lineage tracing defines myofibroblast origin and function in the injured heart, Nat Commun, 7, 10.1038/ncomms12260 Moore-Morris, 2018, Infarct fibroblasts do not derive from bone marrow lineages, Circ Res, 122, 583, 10.1161/CIRCRESAHA.117.311490 Chen, 2020, Chemokines in myocardial infarction, J Cardiovasc Transl Res Dewald, 2003, Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species, Proc Natl Acad Sci U S A, 100, 2700, 10.1073/pnas.0438035100 Frangogiannis, 2002, Evidence for an active inflammatory process in the hibernating human myocardium, Am J Pathol, 160, 1425, 10.1016/S0002-9440(10)62568-0 Feng, 2015, Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via toll-like receptor 7 signaling, J Biol Chem, 290, 26688, 10.1074/jbc.M115.661835 Suetomi, 2019, Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling, Am J Physiol Heart Circ Physiol, 317, H877, 10.1152/ajpheart.00223.2019 Wang, 2018, CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration, Eur Heart J, 39, 1818, 10.1093/eurheartj/ehy085 Suetomi, 2018, Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca(2+)/calmodulin-dependent protein kinase II delta signaling in cardiomyocytes are essential for adverse cardiac remodeling, Circulation, 138, 2530, 10.1161/CIRCULATIONAHA.118.034621 Willeford, 2018, CaMKIIdelta-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis, JCI Insight, 3, 10.1172/jci.insight.97054 Stevenson, 2019, NADPH oxidase 4 regulates inflammation in ischemic heart failure: role of soluble epoxide hydrolase, Antioxid Redox Signal, 31, 39, 10.1089/ars.2018.7548 Frangogiannis, 2007, Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy, Circulation, 115, 584, 10.1161/CIRCULATIONAHA.106.646091 Koyanagi, 2000, Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis, Circulation, 102, 2243, 10.1161/01.CIR.102.18.2243 Kuwahara, 2004, Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?, Hypertension, 43, 739, 10.1161/01.HYP.0000118584.33350.7d Dewald, 2005, CCL2/monocyte chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts, Circ Res, 96, 881, 10.1161/01.RES.0000163017.13772.3a Tan, 2019, Role of CCR2 in the development of streptozotocin-treated diabetic cardiomyopathy, Diabetes, 68, 2063, 10.2337/db18-1231 Sakai, 2006, MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes, J Leukoc Biol, 79, 555, 10.1189/jlb.0305127 Patel, 2018, CCR2(+) monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload, JACC Basic Transl Sci, 3, 230, 10.1016/j.jacbts.2017.12.006 Epelman, 2014, Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation, Immunity, 40, 91, 10.1016/j.immuni.2013.11.019 Dick, 2019, Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction, Nat Immunol, 20, 29, 10.1038/s41590-018-0272-2 Heidt, 2014, Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction, Circ Res, 10.1161/CIRCRESAHA.115.303567 Chen, 2019, Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation, Circ Res, 125, 55, 10.1161/CIRCRESAHA.119.315069 Bajpai, 2019, Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury, Circ Res, 124, 263, 10.1161/CIRCRESAHA.118.314028 Bajpai, 2018, The human heart contains distinct macrophage subsets with divergent origins and functions, Nat Med, 24, 1234, 10.1038/s41591-018-0059-x Nevers, 2017, Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure, J Exp Med, 214, 3311, 10.1084/jem.20161791 Kruglov, 2006, Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts, Am J Physiol Gastrointest Liver Physiol, 290, G765, 10.1152/ajpgi.00308.2005 Dewald, 2004, Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction, Am J Pathol, 164, 665, 10.1016/S0002-9440(10)63154-9 Lubos, 2020, Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy, Basic Res Cardiol, 115, 42, 10.1007/s00395-020-0803-5 Ma, 2015, Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence, Cardiovasc Res, 106, 421, 10.1093/cvr/cvv128 Kaya, 2008, Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis, Circulation, 118, 2063, 10.1161/CIRCULATIONAHA.108.788711 Alard, 2015, Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5, Sci Transl Med, 7, 10.1126/scitranslmed.aad5330 Montecucco, 2012, CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice, Eur Heart J, 33, 1964, 10.1093/eurheartj/ehr127 Dobaczewski, 2010, CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells, Am J Pathol, 176, 2177, 10.2353/ajpath.2010.090759 Saxena, 2014, Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function, Am J Physiol Heart Circ Physiol, 307, H1233, 10.1152/ajpheart.00328.2014 Krebs, 2012, CCR5 deficiency does not reduce hypertensive end-organ damage in mice, Am J Hypertens, 25, 479, 10.1038/ajh.2011.243 Mor, 2019, Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis, Ann Rheum Dis, 78, 1260, 10.1136/annrheumdis-2019-215119 Diny, 2016, Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart, Eur J Immunol, 46, 2749, 10.1002/eji.201646557 Wang, 2019, Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling, Proc Natl Acad Sci U S A, 116, 18455, 10.1073/pnas.1905824116 Strieter, 1995, The functional role of the ELR motif in CXC chemokine-mediated angiogenesis, J Biol Chem, 270, 27348, 10.1074/jbc.270.45.27348 Zhang, 2019, Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats, Biochim Biophys Acta Mol Basis Dis, 1865, 10.1016/j.bbadis.2019.165551 Zhang, 2020, Chemokine receptor CXCR-2 Initiates atrial fibrillation by triggering monocyte mobilization in mice, Hypertension, 76, 381, 10.1161/HYPERTENSIONAHA.120.14698 Martinod, 2017, Peptidylarginine deiminase 4 promotes age-related organ fibrosis, J Exp Med, 214, 439, 10.1084/jem.20160530 Chrysanthopoulou, 2014, Neutrophil extracellular traps promote differentiation and function of fibroblasts, J Pathol, 233, 294, 10.1002/path.4359 Weckbach, 2019, Midkine drives cardiac inflammation by promoting neutrophil trafficking and NETosis in myocarditis, J Exp Med, 216, 350, 10.1084/jem.20181102 Frangogiannis, 2001, Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis, FASEB J, 15, 1428, 10.1096/fj.00-0745fje Bujak, 2009, Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction, Circ Res, 105, 973, 10.1161/CIRCRESAHA.109.199471 Saxena, 2014, CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans, Cardiovasc Res, 103, 217, 10.1093/cvr/cvu138 Lindsey, 2019, Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality, Cardiovasc Res, 115, 395, 10.1093/cvr/cvy211 Mueller, 2008, CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3, J Leukoc Biol, 83, 875, 10.1189/jlb.1006645 Vajen, 2018, Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis, Sci Rep, 8, 10.1038/s41598-018-29026-0 Nagasawa, 1996, Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1, Nature, 382, 635, 10.1038/382635a0 Salvucci, 2002, Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1, Blood, 99, 2703, 10.1182/blood.V99.8.2703 Salcedo, 1999, Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha, Am J Pathol, 154, 1125, 10.1016/S0002-9440(10)65365-5 Doring, 2014, The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease, Front Physiol, 5, 212 Penn, 2012, SDF-1 in myocardial repair, Gene Ther, 19, 583, 10.1038/gt.2012.32 Chu, 2019, CXCR4 antagonism reduces cardiac fibrosis and improves cardiac performance in dilated cardiomyopathy, Front Pharmacol, 10, 117, 10.3389/fphar.2019.00117 Chu, 2015, CXCR4 antagonism attenuates the development of diabetic cardiac fibrosis, PLoS One, 10, 10.1371/journal.pone.0133616 Chu, 2011, CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess, Circ Heart Fail, 4, 651, 10.1161/CIRCHEARTFAILURE.110.960831 Li, 2019, Acetaldehyde dehydrogenase 2 deficiency exacerbates cardiac fibrosis by promoting mobilization and homing of bone marrow fibroblast progenitor cells, J Mol Cell Cardiol, 137, 107, 10.1016/j.yjmcc.2019.10.006 Chu, 2010, Bone marrow-derived cells contribute to fibrosis in the chronically failing heart, Am J Pathol, 176, 1735, 10.2353/ajpath.2010.090574 Jackson, 2017, SDF-1alpha (Stromal Cell-Derived Factor 1alpha) induces cardiac fibroblasts, renal microvascular smooth muscle cells, and glomerular mesangial cells to proliferate, cause hypertrophy, and produce collagen, J Am Heart Assoc, 6, 10.1161/JAHA.117.007253 Di Maggio, 2017, Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction, Biochim Biophys Acta Mol Basis Dis, 1863, 2693, 10.1016/j.bbadis.2017.07.012 Menhaji-Klotz, 2018, Discovery of a novel small-molecule modulator of C-X-C chemokine receptor Type 7 as a treatment for cardiac fibrosis, J Med Chem, 61, 3685, 10.1021/acs.jmedchem.8b00190 Boag, 2015, T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients, J Clin Invest, 125, 3063, 10.1172/JCI80055 Karlmark, 2010, The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes, Hepatology, 52, 1769, 10.1002/hep.23894 Shimizu, 2011, Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney, Hypertens Res, 34, 747, 10.1038/hr.2011.23 Nahrendorf, 2007, The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, J Exp Med, 204, 3037, 10.1084/jem.20070885 Muller, 2017, CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis, PLoS One, 12, 10.1371/journal.pone.0182643 Xuan, 2011, Detrimental effect of fractalkine on myocardial ischaemia and heart failure, Cardiovasc Res, 92, 385, 10.1093/cvr/cvr221 Ahadzadeh, 2018, The chemokine receptor CX3CR1 reduces renal injury in mice with angiotensin II-induced hypertension, Am J Physiol Renal Physiol, 315, F1526, 10.1152/ajprenal.00149.2018 de Zeeuw, 2015, The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial, Lancet Diabetes Endocrinol, 3, 687, 10.1016/S2213-8587(15)00261-2 Menne, 2017, C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria, Nephrol Dial Transplant, 32, 307 Bowler, 2019, Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy, HIV Res Clin Pract, 20, 123, 10.1080/25787489.2020.1719319 Friedman, 2016, Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design, Contemp Clin Trials, 47, 356, 10.1016/j.cct.2016.02.012 Ratziu, 2020, Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the Phase 2b CENTAUR study, Hepatology, 10.1002/hep.31108 Schiattarella, 2020, Metabolic Inflammation in heart failure with preserved ejection fraction, Cardiovasc Res Paulus, 2013, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation, J Am Coll Cardiol, 62, 263, 10.1016/j.jacc.2013.02.092 Hulsmans, 2018, Cardiac macrophages promote diastolic dysfunction, J Exp Med, 215, 423, 10.1084/jem.20171274 Hoefer, 2001, Time course of arteriogenesis following femoral artery occlusion in the rabbit, Cardiovasc Res, 49, 609, 10.1016/S0008-6363(00)00243-1 Saxena, 2008, Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction, Circulation, 117, 2224, 10.1161/CIRCULATIONAHA.107.694992 Kanki, 2011, Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium, Circ Heart Fail, 4, 509, 10.1161/CIRCHEARTFAILURE.110.960302 Sager, 2016, Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure, Circ Res, 119, 853, 10.1161/CIRCRESAHA.116.309001 Bansal, 2019, Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy, Circulation, 139, 206, 10.1161/CIRCULATIONAHA.118.036065 Toyozaki, 2001, Macrophage inflammatory protein-1alpha relates to the recruitment of inflammatory cells in myosin-induced autoimmune myocarditis in rats, Lab Invest, 81, 929, 10.1038/labinvest.3780303 Goser, 2005, Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy, Circulation, 112, 3400, 10.1161/CIRCULATIONAHA.105.572396 Cook, 1995, Requirement of MIP-1 alpha for an inflammatory response to viral infection, Science, 269, 1583, 10.1126/science.7667639 Kukielka, 1995, Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo, J Clin Invest, 95, 89, 10.1172/JCI117680 Ivey, 1995, Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8, J Clin Invest, 95, 2720, 10.1172/JCI117974 Segret, 2007, Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes, J Histochem Cytochem, 55, 141, 10.1369/jhc.6A7050.2006 Ble, 2011, Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritis, Am J Nephrol, 34, 367, 10.1159/000330685 Raghu, 2015, CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab, Eur Respir J, 46, 1740, 10.1183/13993003.01558-2014 Sherman, 2019, Improvement in hepatic fibrosis biomarkers associated with chemokine receptor inactivation through mutation or therapeutic blockade, Clin Infect Dis, 68, 1911, 10.1093/cid/ciy807